News

Venture Global: Rapidly Closing The Valuation Gap With Cheniere
Venture Global's CP2 project approval boosts growth, positioning it as the top U.S. LNG exporter. Explore why LNG demand ...
Institutional Investor2d
Under New Leadership, Vontobel SFA Looks to Ride Wave of Investors Diversifying Away From the U.S.
The new CEO of Vontobel Swiss Financial Advisers is confident that the firm can take advantage of increased desire for ...
Global Investors Have a New Reason to Pull Back From U.S. Debt
After hedging currency risk, foreign investors no longer make money buying American bonds.
Antheia Raises $56 Million in Series C Financing to Fuel Global Commercialization Strategy
Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine supply chains, today announced it has raised $56 million in Series C financing. The new financing will be used to ...
Altimmune Vs. Viking Therapeutics: Evaluating Pipeline Maturity, And Takeover Potential
Discover why Altimmune (ALT) and Viking Therapeutics (VKTX) are top picks for high-risk investors. Click here to read my most ...
What Makes Venture Global (VG) a Prospective Investment Choice?
Sands Capital, an investment management company, released its “Sands Capital Select Growth Strategy” Q1 2025 investor letter.
Could Viking Therapeutics Become the Next Eli Lilly?
Eli Lilly is a global healthcare giant, generating strong growth from a diverse portfolio of blockbuster medications. Viking ...
Opalesque6d
Ninepoint Partners and WP Global Partners team up on private equity
Through this partnership, Ninepoint Institutional Partners LP, the institutional division of Ninepoint, has been appointed as the exclusive capital formation partner in Canada for certain WP Global ...